Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
S2M.ST Stock Summary
Top 10 Correlated ETFs
S2M.ST
In the News
S2M.ST Financial details
Company Rating
Neutral
Market Cap
24.84M
Income
-23.19M
Revenue
6.97M
Book val./share
0.01
Cash/share
0.01
Dividend
-
Dividend %
-
Employees
20
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-0.13
Forward P/E
-
PEG
0.02
P/S
6.13
P/B
0.23
P/C
7.8
P/FCF
-0.66
Quick Ratio
0.95
Current Ratio
1.11
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.46
EPS next Y
-
EPS next Q
-
EPS this Y
-85.5%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-14.67%
Revenue last 5Y
17.61%
Revenue Q/Q
98.49%
EPS Q/Q
-64.72%
-
-
-
-
SMA20
-
SMA50
-27.27%
SMA100
300%
Inst Own
-
Inst Trans
-
ROA
-64%
ROE
-340%
ROC
-1.48%
Gross Margin
76%
Oper. Margin
-474%
Profit Margin
-580%
Payout
-
Shs Outstand
264.3M
Shs Float
255.99M
-
-
-
-
Target Price
-
52W Range
0.018-0.666
52W High
-
52W Low
-
RSI
49.63
Rel Volume
0.19
Avg Volume
10.04M
Volume
1.89M
Perf Week
6.85%
Perf Month
35.42%
Perf Quarter
209.52%
Perf Half Y
178.57%
-
-
-
-
Beta
0.923
-
-
Volatility
0.01%, 0.01%
Prev Close
-3.7%
Price
0.078
Change
-6.25%
S2M.ST Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.07 | 0.56 | 0.18 | 0.2 | 0.06 | |
Net income per share | -0.42 | -0.33 | -0.47 | -1.31 | -0.19 | |
Operating cash flow per share | -0.39 | -0.28 | -0.46 | -1.18 | -0.14 | |
Free cash flow per share | -0.46 | -0.32 | -0.53 | -1.26 | -0.15 | |
Cash per share | 0.35 | 0.55 | 0.22 | 0.16 | 0.01 | |
Book value per share | 0.57 | 0.71 | 0.34 | 0.3 | 0.01 | |
Tangible book value per share | 0.42 | 0.54 | 0.07 | -0.21 | 0.01 | |
Share holders equity per share | 0.57 | 0.71 | 0.34 | 0.3 | 0.01 | |
Interest debt per share | 0.04 | 0.02 | 0.01 | 0.06 | 0 | |
Market cap | 420.46M | 368.53M | 225.65M | 16.16M | 7.29M | |
Enterprise value | 406.51M | 344.21M | 216.38M | 12.44M | 5.77M | |
P/E ratio | -22.68 | -24.43 | -11.1 | -0.52 | -0.32 | |
Price to sales ratio | 135.7 | 14.39 | 29.31 | 3.46 | 1.05 | |
POCF ratio | -24.58 | -28.91 | -11.47 | -0.57 | -0.44 | |
PFCF ratio | -20.76 | -25.02 | -9.91 | -0.54 | -0.41 | |
P/B Ratio | 16.74 | 11.25 | 15.37 | 2.29 | 4.4 | |
PTB ratio | 16.74 | 11.25 | 15.37 | 2.29 | 4.4 | |
EV to sales | 131.2 | 13.44 | 28.1 | 2.66 | 0.83 | |
Enterprise value over EBITDA | -23.82 | -25.23 | -11.8 | -0.48 | -0.41 | |
EV to operating cash flow | -23.77 | -27 | -11 | -0.44 | -0.35 | |
EV to free cash flow | -20.07 | -23.37 | -9.51 | -0.41 | -0.33 | |
Earnings yield | -0.04 | -0.04 | -0.09 | -1.93 | -3.12 | |
Free cash flow yield | -0.05 | -0.04 | -0.1 | -1.86 | -2.42 | |
Debt to equity | 0.06 | 0.03 | 0.01 | -0.03 | 0 | |
Debt to assets | 0.05 | 0.02 | 0.01 | -0.01 | 0 | |
Net debt to EBITDA | 0.82 | 1.78 | 0.51 | 0.14 | 0.11 | |
Current ratio | 4.51 | 3.79 | 1.08 | 0.65 | 0.44 | |
Interest coverage | -181 | -204.47 | -81.49 | -15.66 | 0 | |
Income quality | 0.93 | 0.85 | 0.99 | 1.02 | 0.73 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 3.91 | 0.43 | 1.59 | 0 | 0 | |
Research and developement to revenue | 0.12 | 0.01 | 0.05 | 0.13 | 0 | |
Intangibles to total assets | 0.21 | 0.19 | 0.39 | 0.48 | 0.04 | |
Capex to operating cash flow | 0.18 | 0.16 | 0.16 | 0.07 | 0.07 | |
Capex to revenue | -1.02 | -0.08 | -0.4 | -0.41 | -0.17 | |
Capex to depreciation | -2.48 | -1.53 | -2.07 | -0.99 | -0.67 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.31 | 2.29 | 1.91 | 2.96 | 0.24 | |
ROIC | -0.69 | -0.45 | -1.35 | -4.29 | -9.55 | |
Return on tangible assets | -0.77 | -0.45 | -1.13 | -2.38 | -1.11 | |
Graham Net | 0.31 | 0.41 | -0.03 | -0.41 | -0.12 | |
Working capital | 16.72M | 23.06M | 1.27M | -6.29M | -11.12M | |
Tangible asset value | 18.6M | 25.03M | 3.01M | -5.11M | 713K | |
Net current asset value | 15.89M | 22.85M | 1.27M | -6.29M | -11.12M | |
Invested capital | 0.06 | 0.03 | 0.01 | -0.03 | 0 | |
Average receivables | 2.17M | 2.27M | 2.01M | 3.05M | 2.47M | |
Average payables | 1.26M | 2.67M | 2.29M | 1.38M | 2.62M | |
Average inventory | 2.13M | 2.74M | 3.38M | 4.44M | 5.19M | |
Days sales outstanding | 427.53 | 12.94 | 147.73 | 233.7 | 101.84 | |
Days payables outstanding | -792.83 | 84.32 | 598.36 | -1.31K | 55.56 | |
Days of inventory on hand | -1.09K | 72.45 | 2.22K | -3.85K | 82.6 | |
Receivables turnover | 0.85 | 28.22 | 2.47 | 1.56 | 3.58 | |
Payables turnover | -0.46 | 4.33 | 0.61 | -0.28 | 6.57 | |
Inventory turnover | -0.34 | 5.04 | 0.16 | -0.09 | 4.42 | |
ROE | -0.74 | -0.46 | -1.38 | -4.42 | -13.7 | |
Capex per share | -0.07 | -0.04 | -0.07 | -0.08 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.03 | 0.02 | 0.08 | 0.01 | 0.01 | |
Net income per share | -0.32 | -0.15 | -0.26 | -0.04 | -0.01 | |
Operating cash flow per share | -0.3 | -0.12 | -0.83 | 0.1 | -0.01 | |
Free cash flow per share | -0.33 | -0.12 | -0.84 | 0.1 | -0.01 | |
Cash per share | 0.16 | 0.04 | 0.05 | 0.01 | 0.01 | |
Book value per share | 0.3 | 0.07 | 0.49 | 0.04 | 0.01 | |
Tangible book value per share | -0.21 | -0.3 | 0.13 | 0.03 | 0 | |
Share holders equity per share | 0.3 | 0.07 | 0.49 | 0.04 | 0.01 | |
Interest debt per share | 0 | 0 | 0.02 | 0.02 | 0 | |
Market cap | 16.16M | 22.03M | 9.46M | 4.5M | 16.53M | |
Enterprise value | 12.44M | 20.76M | 7.79M | 3M | 15.01M | |
P/E ratio | -0.53 | -1.11 | -0.28 | -0.19 | -1.08 | |
Price to sales ratio | 24.67 | 29.65 | 3.54 | 3.77 | 6.99 | |
POCF ratio | -2.26 | -5.84 | -0.35 | 0.28 | -11.29 | |
PFCF ratio | -2.08 | -5.64 | -0.35 | 0.29 | -9.2 | |
P/B Ratio | 2.29 | 9.63 | 0.59 | 0.82 | 9.97 | |
PTB ratio | 2.29 | 9.63 | 0.59 | 0.82 | 9.97 | |
EV to sales | 18.99 | 27.94 | 2.92 | 2.52 | 6.34 | |
Enterprise value over EBITDA | -1.91 | -5.01 | -1.7 | -1.03 | -6.34 | |
EV to operating cash flow | -1.74 | -5.5 | -0.29 | 0.19 | -10.25 | |
EV to free cash flow | -1.6 | -5.31 | -0.28 | 0.19 | -8.36 | |
Earnings yield | -0.47 | -0.23 | -0.88 | -1.35 | -0.23 | |
Free cash flow yield | -0.48 | -0.18 | -2.9 | 3.43 | -0.11 | |
Debt to equity | -0.03 | -0.13 | -0.16 | 0 | 0 | |
Debt to assets | -0.01 | -0.01 | -0.06 | 0 | 0 | |
Net debt to EBITDA | 0.57 | 0.31 | 0.36 | 0.51 | 0.64 | |
Current ratio | 0.65 | 0.45 | 1.11 | 0.59 | 0.44 | |
Interest coverage | -21.13 | -22.55 | -1.6 | -1.11 | 0 | |
Income quality | 1.03 | 0.82 | 5.29 | -2.61 | 0.38 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.91 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.48 | 0.55 | 0.26 | 0.04 | 0.04 | |
Capex to operating cash flow | 0.08 | 0.04 | 0.01 | -0.02 | 0.23 | |
Capex to revenue | -0.9 | -0.18 | -0.11 | -0.33 | -0.14 | |
Capex to depreciation | -1.24 | -0.31 | -0.56 | -0.63 | -0.77 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.47 | 0.49 | 1.69 | 0.18 | 0.04 | |
ROIC | -1.07 | -2.38 | -0.38 | -0.64 | -1.69 | |
Return on tangible assets | -0.58 | -0.5 | -0.25 | -0.27 | -0.19 | |
Graham Net | -0.41 | -0.44 | -0.18 | -0.07 | -0.05 | |
Working capital | -6.29M | -10.77M | 3.13M | -7.4M | -11.12M | |
Tangible asset value | -5.11M | -9.7M | 4.09M | 4.44M | 713K | |
Net current asset value | -6.29M | -10.77M | 3.13M | -7.4M | -11.12M | |
Invested capital | -0.03 | -0.13 | -0.16 | 0 | 0 | |
Average receivables | 1.85M | 2.56M | 14.12M | 14.52M | 2.43M | |
Average payables | 1.4M | 1.53M | 1.47M | 2.76M | 3.68M | |
Average inventory | 5.34M | 5.24M | 4.96M | 5.48M | 5.74M | |
Days sales outstanding | 410.75 | 258.61 | 880.08 | 220.77 | 73.99 | |
Days payables outstanding | 1.55K | 1.82K | 170.84 | 73.93 | 60.52 | |
Days of inventory on hand | 4.55K | 7.41K | 484.86 | 120.27 | 89.98 | |
Receivables turnover | 0.22 | 0.35 | 0.1 | 0.41 | 1.22 | |
Payables turnover | 0.06 | 0.05 | 0.53 | 1.22 | 1.49 | |
Inventory turnover | 0.02 | 0.01 | 0.19 | 0.75 | 1 | |
ROE | -1.08 | -2.18 | -0.52 | -1.11 | -2.31 | |
Capex per share | -0.02 | 0 | -0.01 | 0 | 0 |
S2M.ST Frequently Asked Questions
What is S2Medical AB (publ) stock symbol ?
S2Medical AB (publ) is a SE stock and trading under the symbol S2M.ST
What is S2Medical AB (publ) stock quote today ?
S2Medical AB (publ) stock price is $0.078 today.
Is S2Medical AB (publ) stock public?
Yes, S2Medical AB (publ) is a publicly traded company.